Nrx pharmaceuticals, inc. (nasdaq:nrxp) to participate in the h.c. wainwright 5th annual neuro perspectives virtual conference on june 27, 2024

Radnor, pa. , june 20, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical stage pharmaceutical company, today announced that management will participate in the h.c.

NRXP Ratings Summary

NRXP Quant Ranking